In BRCA1/2 mutant ovarian cancer cells that depend on PARP-mediated single-strand repair due to homologous recombination repair (HR) deficiency caused by BRCA gene mutations, a subset of these cells may acquire secondary reversion mutations in the BRCA1/2 genes. This evidence concerns the gene PARP1 and ovarian carcinoma.